Author Elliott Schuchardt argues that federal subsidies and tariffs will fail to bring drug manufacturing home until Washington addresses the overvalued petrodollar.
Knoxville, TN (PRUnderground) November 21st, 2026

Elliott J. Schuchardt, a former candidate for the Tennessee General Assembly, says that the United States is dangerously dependent upon China and other foreign nations for pharmaceutical ingredients. Schuchardt says that drug manufacturing will not return to the United States until the federal government deals with an overvalued dollar.
Schuchardt is the author of America's Achilles Heel: How to Protect Your Family When America Loses the Reserve Currency. In the book, Schuchardt argues that the dollar is artificially overvalued because of the dollar's use in the world's oil markets. Schuchardt argues that the dollar could collapse in value, if the United States does not proactively devalue the dollar.
In a newly published commentary tied to his book, Schuchardt looks at America's dependence on foreign pharmaceuticals. He says that, in the early 1970s, the United States produced 80% to 90% of the "active pharmaceutical ingredients" (APIs) that it consumed. Today, the United States imports nearly 90% of these chemical compounds, primarily from China and India.
According to federal trade and industry data cited in the analysis, China alone supplies roughly 90% to 95% of U.S. imports of ibuprofen, 91% of hydrocortisone, 82% of tetracycline antibiotics, and roughly 94% of the raw chemical building blocks required to make amoxicillin.
While the federal government has rolled out initiatives to bring back manufacturing to the United States, Schuchardt says that these measures treat the symptoms rather than the underlying economic cause.
"Politicians in Washington express shock at our medical vulnerability - yet they ignore the mathematical reality driving factories overseas," says Schuchardt. "Since the 1970s, the petrodollar system has forced central banks and nations around the world to hoard U.S. dollars to buy oil. That perpetual global demand keeps the dollar priced 20% to 40% above its competitive equilibrium, acting as a permanent, crippling tariff on American manufacturers."
Schuchardt notes that recent federal tariff packages largely exempt generic drugs--which account for 90% of American prescriptions. He says that imposing duties on inexpensive foreign generics would trigger immediate price spikes and pharmacy shortages, something that Washington, D.C. does not want to do.
The analysis warns of severe economic and public health consequences if the U.S. dollar were to lose its global reserve status and rapidly lose value.
"If the petrodollar monopoly unravels and the dollar plunges overnight, foreign suppliers in China and India will demand payment in gold, commodities, or stronger currencies before shipping chemical precursors," Schuchardt added. "Because America dismantled its domestic chemical plants decades ago, we would be unable to afford foreign medicine and unable to manufacture our own. No amount of taxpayer grants can make domestic plants viable without endless life support until Washington executes an orderly devaluation of the dollar, similar to the 1985 Plaza Accord."
About Elliott Schuchardt
Elliott Schuchardt is a politician, author and economic commentator who writes on monetary policy, national security, and U.S. industrial competitiveness. He is the author of America's Achilles Heel: How to Protect Your Family When America Loses the Reserve Currency. In 2026, Schuchardt was a candidate for the Tennessee General Assembly.
Media Contact:
Elliott J. Schuchardt
Phone: (865) 304-4374
E-mail: elliott@elliottschuchardt.com
Website: www.elliottschuchardt.com